139 related articles for article (PubMed ID: 11600390)
1. Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients.
Ribera E; Pou L; Fernandez-Sola A; Campos F; Lopez RM; Ocaña I; Ruiz I; Pahissa A
Antimicrob Agents Chemother; 2001 Nov; 45(11):3238-41. PubMed ID: 11600390
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioavailability of trimethoprim-sulfamethoxazole in alpacas.
Chakwenya J; Lakritz J; Tyler J; Fales WH; James-Kracke M; Smith K; Holle J
J Vet Pharmacol Ther; 2002 Oct; 25(5):321-7. PubMed ID: 12423221
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.
Stein GE; Gurwith D; Gurwith M
Antimicrob Agents Chemother; 1988 Jun; 32(6):802-6. PubMed ID: 3046481
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after oral single- and multiple-dose administration to healthy pigs.
Mengelers MJ; van Gogh ER; Huveneers MB; Hougee PE; Kuiper HA; Pijpers A; Verheijden JH; van Miert AS
Vet Res Commun; 2001 Aug; 25(6):461-81. PubMed ID: 11519678
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients.
Buijs BS; van den Berk GE; Boateng CP; Hoepelman AI; van Maarseveen EM; Arends JE
AIDS; 2015 Apr; 29(7):785-91. PubMed ID: 25985401
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of sulfamethoxazole and trimethoprim in donkeys, mules, and horses.
Peck KE; Matthews NS; Taylor TS; Mealey KL
Am J Vet Res; 2002 Mar; 63(3):349-53. PubMed ID: 11911569
[TBL] [Abstract][Full Text] [Related]
7. Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia.
Yang JJ; Huang CH; Liu CE; Tang HJ; Yang CJ; Lee YC; Lee KY; Tsai MS; Lin SW; Chen YH; Lu PL; Hung CC
PLoS One; 2014; 9(9):e106141. PubMed ID: 25184238
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after intravenous administration to healthy and pneumonic pigs.
Mengelers MJ; Van Gogh ER; Kuiper HA; Pijpers A; Verheijden JH; Van Miert AS
J Vet Pharmacol Ther; 1995 Aug; 18(4):243-53. PubMed ID: 8583537
[TBL] [Abstract][Full Text] [Related]
9. Trimethoprim/sulfamethoxazole does not affect the steady-state disposition of indinavir.
Sturgill MG; Seibold JR; Boruchoff SE; Yeh KC; Haddix H; Deutsch P
J Clin Pharmacol; 1999 Oct; 39(10):1077-84. PubMed ID: 10516943
[TBL] [Abstract][Full Text] [Related]
10. Cotrimoxazole plasma levels, dialyzer clearance and total removal by extended dialysis in a patient with acute kidney injury: risk of under-dosing using current dosing recommendations.
Clajus C; Kühn-Velten WN; Schmidt JJ; Lorenzen JM; Pietsch D; Beutel G; Kielstein JT
BMC Pharmacol Toxicol; 2013 Apr; 14():19. PubMed ID: 23551893
[TBL] [Abstract][Full Text] [Related]
11. Oral absorption of trimethoprim-sulfamethoxazole in patients with AIDS.
Klepser ME; Zhu Z; Nicolau DP; Banevicius MA; Belliveau PP; Ross JW; Broisman L; Quintiliani R; Nightingale CH
Pharmacotherapy; 1996; 16(4):656-62. PubMed ID: 8840373
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection.
Wong YY; Rakasz EG; Gasper DJ; Friedrich TC; Trepanier LA
Toxicology; 2016 Aug; 368-369():10-18. PubMed ID: 27565715
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of trimethoprim and sulfamethoxazole in llamas after orogastric administration.
Snook CS; Poppenga RH; Rudik I; Sweeney RW
J Vet Pharmacol Ther; 2002 Oct; 25(5):383-6. PubMed ID: 12423230
[No Abstract] [Full Text] [Related]
14. Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268.
Para MF; Finkelstein D; Becker S; Dohn M; Walawander A; Black JR
J Acquir Immune Defic Syndr; 2000 Aug; 24(4):337-43. PubMed ID: 11015150
[TBL] [Abstract][Full Text] [Related]
15. Blunted humoral response to influenza vaccination in patients exposed to zidovudine plus trimethoprim-sulfamethoxazole.
Feola DJ; Garvy BA; Rapp RP; Thornton AC
Pharmacotherapy; 2007 Jul; 27(7):937-47. PubMed ID: 17594199
[TBL] [Abstract][Full Text] [Related]
16. Quantification of Serum Sulfamethoxazole and Trimethoprim by Ultra-fast Solid-Phase Extraction-Tandem Mass Spectrometry.
Fatica E; Faber J; Gaffron C; Bjergum M; Langman L; Jannetto P
Ther Drug Monit; 2020 Oct; 42(5):724-732. PubMed ID: 32618880
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical worsening in tuberculosis during therapy in an HIV-infected patient.
Mofredj A; Guérin JM; Leibinger F; Masmoudi R
Infection; 1996; 24(5):390-1. PubMed ID: 8923052
[No Abstract] [Full Text] [Related]
18. Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines.
Pressiat C; Mea-Assande V; Yonaba C; Treluyer JM; Dahourou DL; Amorissani-Folquet M; Blanche S; Eboua F; Ye D; Lui G; Malateste K; Zheng Y; Leroy V; Hirt D;
Br J Clin Pharmacol; 2017 Dec; 83(12):2729-2740. PubMed ID: 28800382
[TBL] [Abstract][Full Text] [Related]
19. Trimethoprim and sulfamethoxazole transmembrane clearance during modeled continuous renal replacement therapy.
Kesner JM; Yardman-Frank JM; Mercier RC; Wong CS; Walker SE; Argyres DP; Vilay AM
Blood Purif; 2014; 38(3-4):195-202. PubMed ID: 25531772
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
Grim SA; Rapp RP; Martin CA; Evans ME
Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
